Vaginal Cream
Over-the-CounterNama merek: FemiClear Infection Protection
About This Medication
Topical product applied to the skin for localized treatment and symptom relief.
Bahan Aktif
| Bahan | Kekuatan |
|---|---|
| Melaleuca Cajuputi Whole | - |
| Thymol | - |
Indikasi & Penggunaan
Dosis & Cara Pemberian
Peringatan & Tindakan Pencegahan
For vaginal use only. FemiClear may damage condoms and diaphragms and cause them to fail. FemiClear does not prevent sexually transmitted infections (STIs). Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting STIs. FemiClear does not eliminate the risk of infections.
Frequently Asked Questions
This product is intended to help prevent bacterial vaginosis (BV) and yeast infections, and to moisturize.
Directions Adults and children 12 years or over: Wash hands before and after use. Squeeze desired amount into applicator. Insert applicator into vagina and inject cream. Clean applicator after use and reuse. Children under 12 years: ask a doctor
For vaginal use only. FemiClear may damage condoms and diaphragms and cause them to fail. FemiClear does not prevent sexually transmitted infections (STIs). Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting STIs. FemiClear does not eliminate the risk of infections.
Vaginal Cream is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Vaginal Cream drug label (National Library of Medicine)
- • openFDA — Vaginal Cream label data (U.S. Food & Drug Administration)
- • NDC Directory — Vaginal Cream (FDA National Drug Code)
Penafian Medis
Informasi di halaman ini hanya dimaksudkan untuk tujuan pendidikan dan tidak boleh digunakan sebagai pengganti saran medis profesional, diagnosis, atau pengobatan.
Selalu cari saran dari dokter atau penyedia layanan kesehatan berkualifikasi lainnya untuk pertanyaan yang Anda miliki mengenai kondisi medis atau obat.
Sumber data: DailyMed (NLM), openFDA, MFDS